HPV Vaccine Leads to Sharp Decline in Cervical Cancer Deaths Among Young Women

Cervical cancer deaths among young American women have dropped by 62% in the last decade, largely attributed to the Gardasil HPV vaccine. The vaccine, approved in 2006, targets strains of HPV responsible for 70% of cervical cancers. Despite the success, HPV vaccination rates in the US have stagnated, highlighting the need for improved coverage. The study, published in JAMA, underscores the vaccine's potential to prevent various cancers, not just cervical, and calls for broader vaccination efforts.